NEWS
CSL set to invest $313m to bulk up flu, COVID-19 mRNA tech
MELBOURNE: Blood products giant CSL is investing at least $US200 million ($313 million) to beef… read more
Bids now due for Medical portfolio says Goldman Sachs
SYDNEY: Bids were due on Monday in the contest for Medical Property Trust’s Healthscope portfolio… read more
IFM calls in bankers for PRP Diagnostic
SYDNEY: RBC Capital Markets has front-row seats to IFM Investors’ run at PRP Diagnostic Imaging… read more
15 new senior healthcare executives sought for key roles
MELBOURNE: Fifteen senior healthcare, aged and retirement village executive positions remain open. New positions listed… read more
